LifeSci Capital Downgrades Larimar Therapeutics (LRMR) to Market Perform
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $4.36 +2.11%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
LifeSci Capital analyst Patrick Dolezal downgraded Larimar Therapeutics (NASDAQ: LRMR) from Outperform to Market Perform with a price target of $3.00.
For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.
Shares of Larimar Therapeutics closed at $4.01 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Lake Street Downgrades SoundThinking (SSTI) to Hold
- Axis Capital Limited Downgrades Tata Motors Passenger Vehicles (TMPV:IN) to Sell (4)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
